Author

E. K. Kong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:multiome· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Korkut· 1 shared B. Bozorgui· 1 shared K. Thapa· 1 shared K. Yun· 1 shared M. Kinali· 1 shared M. Vishnoi· 1 shared N. H. Abdelfattah· 1 shared O. Babur· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Korkut

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A prognostic matrix code defines functional glioblastoma phenotypes and niches.

M. Vishnoi, Z. Dereli, Z. Yin, E. K. Kong, M. Kinali, K. Thapa, O. Babur, K. Yun, N. H. Abdelfattah, X. Li, B. Bozorgui, R. C. Rostomily, A. Korkut

This paper identifies a matrix code based on extracellular core matrix proteins that categorizes glioblastoma tumors into prognostic groups and predicts responses to PD1 blockade.

bioRxiv · Jun 6, 2023 · PreprintCancer Biology